BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 14/07/2026

FDA Announces Final Guidance for Clinical Investigations of Psychedelic Drugs

The US Food and Drug Administration (FDA) has released a final guidance document outlining considerations for industry sponsors developing psychedelic drugs for medical conditions, following a draft issued in June 2023.

Source: Federal Register — Health and Human ServicesOpen original release →